| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 5.07e-10 | 34 | 178 | 8 | GO:0015125 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.31e-09 | 14 | 178 | 6 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 4.10e-08 | 23 | 178 | 6 | GO:0034235 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.10e-07 | 90 | 178 | 9 | GO:0008028 | |
| GeneOntologyMolecularFunction | filamin binding | 1.85e-07 | 29 | 178 | 6 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.85e-07 | 29 | 178 | 6 | GO:0035325 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 2.01e-07 | 70 | 178 | 8 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 2.79e-07 | 73 | 178 | 8 | GO:0170055 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | ABCC3 SLC4A8 PSG1 PSG3 PSG4 PSG6 PSG9 SLC26A4 SLC13A3 SLC16A6 ABCB11 SLC39A6 PSG8 | 2.39e-06 | 293 | 178 | 13 | GO:0008514 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | ABCC3 PSG1 PSG3 PSG4 PSG6 PSG9 SLC26A4 SLC13A3 SLC16A6 ABCB11 PSG8 | 2.62e-06 | 207 | 178 | 11 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | ABCC3 PSG1 PSG3 PSG4 PSG6 PSG9 SLC26A4 SLC13A3 SLC16A6 ABCB11 PSG8 | 2.74e-06 | 208 | 178 | 11 | GO:0005342 |
| GeneOntologyMolecularFunction | glycolipid binding | 4.69e-06 | 49 | 178 | 6 | GO:0051861 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC3 NVL UPF1 OLA1 ATP13A2 ABCB11 DDX20 CHD6 KIF18B DHX29 TAP2 FIGNL1 SNRNP200 MOV10 | 4.33e-05 | 441 | 178 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | DCDC2 HIP1 ABL2 MYOT MYO5A PSG1 PSG3 PSG4 PSG6 PSG9 APC2 TOGARAM2 FHOD3 SPAG9 ARPC3 MAGI2 BRCA2 ARHGEF10 KCNMA1 PSG8 KIF18B ALDOC NOS3 TTLL13 | 4.45e-05 | 1099 | 178 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | protein kinase activity | CAD ABL2 SPEG STK26 MINK1 PLK5 SIK3 TYRO3 STK10 CIITA TESK2 SIK2 PRKCB ATM FGFR4 MOS | 9.78e-05 | 600 | 178 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | actin binding | HIP1 ABL2 MYOT MYO5A PSG1 PSG3 PSG4 PSG6 PSG9 FHOD3 ARPC3 KCNMA1 PSG8 NOS3 | 1.04e-04 | 479 | 178 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.15e-04 | 210 | 178 | 9 | GO:0019903 | |
| GeneOntologyMolecularFunction | kinesin binding | 1.29e-04 | 55 | 178 | 5 | GO:0019894 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | HIP1 SNX3 PSG1 PSG3 PSG4 PSG6 PSG9 HS1BP3 ATP13A2 DENND1A PSG8 | 1.31e-04 | 316 | 178 | 11 | GO:0035091 |
| GeneOntologyMolecularFunction | phosphatase binding | 1.34e-04 | 264 | 178 | 10 | GO:0019902 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.28e-04 | 230 | 178 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase activity | 2.36e-04 | 3 | 178 | 2 | GO:0004517 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | DPAGT1 CAD ABL2 SPEG STK26 MINK1 PLK5 YRDC SIK3 TERT AK8 TYRO3 STK10 CIITA TESK2 SIK2 PRKCB ATM FGFR4 MOS | 2.75e-04 | 938 | 178 | 20 | GO:0016772 |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.84e-04 | 196 | 178 | 8 | GO:0005319 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC3 MYO5A NVL UPF1 OLA1 ATP13A2 ABCB11 DDX20 CHD6 KIF18B DHX29 TAP2 FIGNL1 SNRNP200 MOV10 | 4.12e-04 | 614 | 178 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | protein serine kinase activity | 4.29e-04 | 363 | 178 | 11 | GO:0106310 | |
| GeneOntologyMolecularFunction | ABC-type bile acid transporter activity | 4.69e-04 | 4 | 178 | 2 | GO:0015432 | |
| GeneOntologyMolecularFunction | tetrahydrobiopterin binding | 4.69e-04 | 4 | 178 | 2 | GO:0034617 | |
| GeneOntologyMolecularFunction | ATPase-coupled organic acid transmembrane transporter activity | 4.69e-04 | 4 | 178 | 2 | GO:0033283 | |
| GeneOntologyMolecularFunction | ATPase-coupled monocarboxylic acid transmembrane transporter activity | 4.69e-04 | 4 | 178 | 2 | GO:0033285 | |
| GeneOntologyMolecularFunction | ATPase-coupled carboxylic acid transmembrane transporter activity | 4.69e-04 | 4 | 178 | 2 | GO:0033284 | |
| GeneOntologyMolecularFunction | kinase activity | CAD ABL2 SPEG STK26 MINK1 PLK5 SIK3 AK8 TYRO3 STK10 CIITA TESK2 SIK2 PRKCB ATM FGFR4 MOS | 4.98e-04 | 764 | 178 | 17 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CAD ABL2 SPEG STK26 MINK1 PLK5 SIK3 TYRO3 STK10 CIITA TESK2 SIK2 PRKCB ATM FGFR4 MOS | 6.28e-04 | 709 | 178 | 16 | GO:0016773 |
| GeneOntologyMolecularFunction | RNA helicase activity | 6.64e-04 | 78 | 178 | 5 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 7.45e-04 | 80 | 178 | 5 | GO:0008186 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 9.36e-04 | 173 | 178 | 7 | GO:0070851 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 9.46e-04 | 49 | 178 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | HIP1 CEBPA PSG1 PSG3 PSG4 PSG6 PSG9 STK26 TERT AXIN1 STK10 RASIP1 PSG8 TAP2 LILRB5 TPD52 FOXP3 | 1.02e-03 | 815 | 178 | 17 | GO:0042803 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | MYCBP2 DENND11 DENND1A VPS9D1 ARHGEF10 RAPGEF3 RAB3GAP2 PLCE1 | 1.13e-03 | 231 | 178 | 8 | GO:0005085 |
| GeneOntologyMolecularFunction | cAMP binding | 1.39e-03 | 25 | 178 | 3 | GO:0030552 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 2.14e-03 | 61 | 178 | 4 | GO:1901682 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 2.21e-03 | 149 | 178 | 6 | GO:1990782 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 2.26e-03 | 446 | 178 | 11 | GO:0004674 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate binding | 2.61e-03 | 31 | 178 | 3 | GO:0080025 | |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 2.73e-03 | 9 | 178 | 2 | GO:0034040 | |
| GeneOntologyMolecularFunction | arginine binding | 2.73e-03 | 9 | 178 | 2 | GO:0034618 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 2.86e-03 | 32 | 178 | 3 | GO:0015106 | |
| GeneOntologyMolecularFunction | helicase activity | 2.96e-03 | 158 | 178 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 3.11e-03 | 398 | 178 | 10 | GO:0046982 | |
| GeneOntologyMolecularFunction | phospholipid binding | HIP1 SNX3 PSG1 PSG3 PSG4 PSG6 PSG9 SYT17 HS1BP3 ATP13A2 DENND1A PSG8 | 3.81e-03 | 548 | 178 | 12 | GO:0005543 |
| GeneOntologyMolecularFunction | NF-kappaB binding | 4.01e-03 | 36 | 178 | 3 | GO:0051059 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 9.72e-10 | 14 | 175 | 6 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 1.61e-09 | 15 | 175 | 6 | GO:0070347 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 1.61e-09 | 15 | 175 | 6 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.61e-09 | 15 | 175 | 6 | GO:0002859 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 1.61e-09 | 15 | 175 | 6 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 2.55e-09 | 16 | 175 | 6 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 3.92e-09 | 17 | 175 | 6 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 3.92e-09 | 17 | 175 | 6 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 3.92e-09 | 17 | 175 | 6 | GO:0038158 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 5.42e-09 | 47 | 175 | 8 | GO:0015721 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 5.84e-09 | 18 | 175 | 6 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 6.21e-09 | 31 | 175 | 7 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 1.20e-08 | 20 | 175 | 6 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.67e-08 | 21 | 175 | 6 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.67e-08 | 21 | 175 | 6 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.67e-08 | 21 | 175 | 6 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 2.28e-08 | 22 | 175 | 6 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.07e-08 | 23 | 175 | 6 | GO:0002858 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 3.07e-08 | 23 | 175 | 6 | GO:0090331 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 4.02e-08 | 60 | 175 | 8 | GO:0030851 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 4.06e-08 | 24 | 175 | 6 | GO:0002855 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 4.06e-08 | 24 | 175 | 6 | GO:2001214 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 4.06e-08 | 24 | 175 | 6 | GO:0002420 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 4.13e-08 | 40 | 175 | 7 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 4.95e-08 | 41 | 175 | 7 | GO:0002716 | |
| GeneOntologyBiologicalProcess | receptor internalization | ANKRD13D ANKRD13B HIP1 PSG1 PSG3 PSG4 PSG6 PSG9 SYT17 MAGI2 PSG8 SCRIB | 5.20e-08 | 182 | 175 | 12 | GO:0031623 |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 5.30e-08 | 25 | 175 | 6 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 5.30e-08 | 25 | 175 | 6 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 8.74e-08 | 27 | 175 | 6 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 1.06e-07 | 124 | 175 | 10 | GO:0050672 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.10e-07 | 28 | 175 | 6 | GO:0034111 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 1.14e-07 | 46 | 175 | 7 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 1.14e-07 | 46 | 175 | 7 | GO:0072574 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | 1.23e-07 | 126 | 175 | 10 | GO:0032945 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 1.33e-07 | 47 | 175 | 7 | GO:0001911 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 1.38e-07 | 29 | 175 | 6 | GO:2001212 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.54e-07 | 71 | 175 | 8 | GO:0002347 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 1.79e-07 | 49 | 175 | 7 | GO:0072576 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | 2.20e-07 | 134 | 175 | 10 | GO:0070664 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 2.58e-07 | 32 | 175 | 6 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 2.58e-07 | 32 | 175 | 6 | GO:0045779 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 2.58e-07 | 32 | 175 | 6 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte activation | PSG1 PSG3 PSG4 PSG6 PSG9 FGL2 TYRO3 PSG8 ATM SCRIB PDCD1LG2 FOXP3 | 2.61e-07 | 211 | 175 | 12 | GO:0051250 |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 2.72e-07 | 52 | 175 | 7 | GO:0031342 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 3.14e-07 | 33 | 175 | 6 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 3.14e-07 | 33 | 175 | 6 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 3.26e-07 | 107 | 175 | 9 | GO:0042130 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 3.78e-07 | 34 | 175 | 6 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 3.78e-07 | 34 | 175 | 6 | GO:0046851 | |
| GeneOntologyBiologicalProcess | negative regulation of cell activation | PSG1 PSG3 PSG4 PSG6 PSG9 FGL2 TYRO3 PSG8 ATM SCRIB NOS3 PDCD1LG2 FOXP3 | 4.29e-07 | 264 | 175 | 13 | GO:0050866 |
| GeneOntologyBiologicalProcess | insulin metabolic process | 4.53e-07 | 35 | 175 | 6 | GO:1901142 | |
| GeneOntologyBiologicalProcess | hemopoiesis | KLF11 TRAF6 CEBPA ABL2 CEBPE PSG1 BTNL8 PSG3 PSG4 PSG6 PSG9 AHCTF1 MINK1 HS1BP3 FGL2 KLF2 ESCO2 FANCD2 TYRO3 ZSWIM9 BRCA2 LMBR1L PSG8 ATM TACC3 LILRB5 NOTCH2 TPD52 FOXP3 | 4.65e-07 | 1223 | 175 | 29 | GO:0030097 |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 5.25e-07 | 83 | 175 | 8 | GO:0002707 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 6.49e-07 | 116 | 175 | 9 | GO:0045670 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 6.60e-07 | 59 | 175 | 7 | GO:0045671 | |
| GeneOntologyBiologicalProcess | negative regulation of response to biotic stimulus | 6.68e-07 | 151 | 175 | 10 | GO:0002832 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 7.54e-07 | 38 | 175 | 6 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 8.85e-07 | 39 | 175 | 6 | GO:0045717 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | TRAF6 CEBPA ABL2 CEBPE PSG1 BTNL8 PSG3 PSG4 PSG6 PSG9 MINK1 HS1BP3 FGL2 FANCD2 TYRO3 LMBR1L PSG8 ATM LILRB5 NOTCH2 TPD52 FOXP3 | 9.78e-07 | 789 | 175 | 22 | GO:0002521 |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte activation | PSG1 PSG3 PSG4 PSG6 PSG9 FGL2 TYRO3 PSG8 ATM SCRIB PDCD1LG2 FOXP3 | 1.03e-06 | 240 | 175 | 12 | GO:0002695 |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 1.07e-06 | 159 | 175 | 10 | GO:1903707 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | ANKRD13D ANKRD13B HIP1 PSG1 PSG3 PSG4 PSG6 PSG9 SYT17 DNAJC6 MAGI2 LMBR1L PSG8 SCRIB | 1.18e-06 | 337 | 175 | 14 | GO:0006898 |
| GeneOntologyBiologicalProcess | cell activation | TRAF6 CEBPA ABL2 PSG1 BTNL8 PSG3 PSG4 PSG6 PSG9 MINK1 HS1BP3 FGL2 FANCD2 TYRO3 LMBR1L KMT5B PRMT5 SLC39A6 PRKCB PSG8 IL17RA ATM SCRIB FYB1 NOS3 LILRB5 NOTCH2 TPD52 PDCD1LG2 FOXP3 | 1.22e-06 | 1356 | 175 | 30 | GO:0001775 |
| GeneOntologyBiologicalProcess | bone remodeling | 1.39e-06 | 127 | 175 | 9 | GO:0046849 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 1.39e-06 | 42 | 175 | 6 | GO:0090330 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 1.43e-06 | 66 | 175 | 7 | GO:0010543 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 1.61e-06 | 96 | 175 | 8 | GO:0002704 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 1.94e-06 | 69 | 175 | 7 | GO:0030195 | |
| GeneOntologyBiologicalProcess | bone resorption | 2.03e-06 | 99 | 175 | 8 | GO:0045453 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell activation | 2.08e-06 | 171 | 175 | 10 | GO:0050868 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 2.12e-06 | 45 | 175 | 6 | GO:0048521 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 2.15e-06 | 70 | 175 | 7 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 2.15e-06 | 70 | 175 | 7 | GO:1900047 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 2.60e-06 | 72 | 175 | 7 | GO:0050819 | |
| GeneOntologyBiologicalProcess | leukocyte activation | TRAF6 CEBPA ABL2 PSG1 BTNL8 PSG3 PSG4 PSG6 PSG9 MINK1 HS1BP3 FGL2 FANCD2 TYRO3 LMBR1L KMT5B SLC39A6 PRKCB PSG8 ATM SCRIB FYB1 LILRB5 NOTCH2 TPD52 PDCD1LG2 FOXP3 | 2.64e-06 | 1186 | 175 | 27 | GO:0045321 |
| GeneOntologyBiologicalProcess | lymphocyte activation | TRAF6 ABL2 PSG1 BTNL8 PSG3 PSG4 PSG6 PSG9 MINK1 HS1BP3 FGL2 FANCD2 TYRO3 LMBR1L KMT5B SLC39A6 PRKCB PSG8 ATM SCRIB NOTCH2 TPD52 PDCD1LG2 FOXP3 | 2.75e-06 | 976 | 175 | 24 | GO:0046649 |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 2.75e-06 | 47 | 175 | 6 | GO:0034104 | |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 2.95e-06 | 139 | 175 | 9 | GO:0007173 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 3.54e-06 | 49 | 175 | 6 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 3.75e-06 | 76 | 175 | 7 | GO:0042269 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 3.99e-06 | 50 | 175 | 6 | GO:0002834 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 5.29e-06 | 80 | 175 | 7 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 5.29e-06 | 80 | 175 | 7 | GO:0046850 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 5.65e-06 | 53 | 175 | 6 | GO:0034110 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 5.83e-06 | 151 | 175 | 9 | GO:1902106 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte cell-cell adhesion | 5.85e-06 | 192 | 175 | 10 | GO:1903038 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 5.86e-06 | 114 | 175 | 8 | GO:0045824 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | HIP1 TRAF6 ABL2 PSG1 PSG3 PSG4 PSG6 PSG9 APC2 NVL TERT DENND1A AXIN1 TYRO3 MAGI2 ARHGEF10 RAPGEF3 NUS1 PSG8 FGFR4 SCRIB NOS1 NOS3 NOTCH2 | 6.64e-06 | 1028 | 175 | 24 | GO:0043085 |
| GeneOntologyBiologicalProcess | endocytosis | ANKRD13D ANKRD13B HIP1 SNX3 ABL2 CEBPE PSG1 PSG3 PSG4 PSG6 PSG9 SYT17 CARMIL1 DNAJC6 DENND1A ARPC3 TYRO3 MAGI2 LMBR1L PSG8 SCRIB | 7.51e-06 | 827 | 175 | 21 | GO:0006897 |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 7.82e-06 | 56 | 175 | 6 | GO:0002418 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 7.94e-06 | 85 | 175 | 7 | GO:1903670 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 7.94e-06 | 85 | 175 | 7 | GO:0002762 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | ABCC3 SLC4A8 PSG1 PSG3 PSG4 PSG6 PSG9 SLC13A3 KLF2 KCNMA1 PSG8 NOS1 NOS3 | 8.00e-06 | 344 | 175 | 13 | GO:0003018 |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 8.58e-06 | 86 | 175 | 7 | GO:0042058 | |
| GeneOntologyBiologicalProcess | liver development | 9.15e-06 | 202 | 175 | 10 | GO:0001889 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 9.27e-06 | 87 | 175 | 7 | GO:0001974 | |
| GeneOntologyBiologicalProcess | ERBB signaling pathway | 9.33e-06 | 160 | 175 | 9 | GO:0038127 | |
| GeneOntologyBiologicalProcess | osteoclast differentiation | 1.03e-05 | 162 | 175 | 9 | GO:0030316 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 1.04e-05 | 205 | 175 | 10 | GO:0061008 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion | ABL2 PSG1 PSG3 PSG4 PSG6 PSG9 FGL2 PSG8 SCRIB PDCD1LG2 FOXP3 | 1.07e-05 | 252 | 175 | 11 | GO:0022408 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 2.44e-09 | 16 | 176 | 6 | GO:0070021 | |
| GeneOntologyCellularComponent | ciliary membrane | 1.78e-06 | 98 | 176 | 8 | GO:0060170 | |
| GeneOntologyCellularComponent | basal plasma membrane | ABCC3 SLC4A8 PSG1 PSG3 PSG4 PSG6 PSG9 SLC13A3 SLC16A6 RAPGEF3 ABCB11 PALM PSG8 SCRIB | 1.92e-06 | 354 | 176 | 14 | GO:0009925 |
| GeneOntologyCellularComponent | apical part of cell | SLC4A8 PSG1 PSG3 PSG4 PSG6 PSG9 SLC26A4 STK26 PARD6A LZTS1 RAPGEF3 KCNMA1 ABCB11 SLC39A6 PSG8 SCRIB PATJ NOS3 | 2.79e-06 | 592 | 176 | 18 | GO:0045177 |
| GeneOntologyCellularComponent | basolateral plasma membrane | ABCC3 SLC4A8 PSG1 PSG3 PSG4 PSG6 PSG9 SLC13A3 SLC16A6 ABCB11 PALM PSG8 SCRIB | 3.38e-06 | 320 | 176 | 13 | GO:0016323 |
| GeneOntologyCellularComponent | apical plasma membrane | SLC4A8 PSG1 PSG3 PSG4 PSG6 PSG9 SLC26A4 STK26 PARD6A LZTS1 KCNMA1 ABCB11 SLC39A6 PSG8 SCRIB PATJ | 3.87e-06 | 487 | 176 | 16 | GO:0016324 |
| GeneOntologyCellularComponent | cell projection membrane | PSG1 PSG3 PSG4 PSG6 PSG9 SLC26A4 APC2 BBS1 PLXND1 RAPGEF3 PALM SLC39A6 PRKCB PSG8 CNGB1 | 3.94e-06 | 431 | 176 | 15 | GO:0031253 |
| GeneOntologyCellularComponent | basal part of cell | ABCC3 SLC4A8 PSG1 PSG3 PSG4 PSG6 PSG9 SLC13A3 SLC16A6 RAPGEF3 ABCB11 PALM PSG8 SCRIB | 4.11e-06 | 378 | 176 | 14 | GO:0045178 |
| GeneOntologyCellularComponent | cell-cell junction | COL13A1 PSG1 PSG3 PSG4 PSG6 PSG9 EVPL MAGI2 RASIP1 TGM1 PTPRK PARD6A ABCB11 PSG8 FGFR4 SCRIB PATJ | 1.10e-05 | 591 | 176 | 17 | GO:0005911 |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.10e-05 | 90 | 176 | 7 | GO:0016328 | |
| GeneOntologyCellularComponent | anchoring junction | KLF11 COL13A1 PSG1 EFS PSG3 PSG4 PSG6 PSG9 EVPL ARPC3 MAGI2 RASIP1 TGM1 PTPRK PARD6A ABCB11 PSG8 FGFR4 SCRIB PATJ FYB1 | 7.66e-05 | 976 | 176 | 21 | GO:0070161 |
| GeneOntologyCellularComponent | adherens junction | 8.06e-05 | 212 | 176 | 9 | GO:0005912 | |
| GeneOntologyCellularComponent | lamellipodium | 1.50e-04 | 230 | 176 | 9 | GO:0030027 | |
| GeneOntologyCellularComponent | axon | CAD SLC4A8 MYOT MYO5A MYCBP2 MINK1 PLXND1 DCC ARPC3 PTPRK PARD6A RAPGEF3 KCNMA1 PALM PRKCB IGSF9 ALDOC NOS1 CNGB1 | 1.92e-04 | 891 | 176 | 19 | GO:0030424 |
| GeneOntologyCellularComponent | cell leading edge | ABL2 MYO5A CARMIL1 APC2 PLXND1 ARPC3 PTPRK PARD6A RAPGEF3 PALM SLC39A6 SCRIB PLCE1 | 3.30e-04 | 500 | 176 | 13 | GO:0031252 |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 3.76e-04 | 157 | 176 | 7 | GO:1902554 | |
| GeneOntologyCellularComponent | T cell receptor complex | 4.71e-04 | 163 | 176 | 7 | GO:0042101 | |
| GeneOntologyCellularComponent | cilium | DCDC2 TTLL3 MYO5A PSG1 PSG3 PSG4 PSG6 PSG9 TOGARAM2 BBS1 AK8 BBS10 MAGI2 PTPRK PSG8 CNGB1 NOTCH2 TTLL13 | 5.93e-04 | 898 | 176 | 18 | GO:0005929 |
| GeneOntologyCellularComponent | protein kinase complex | 6.05e-04 | 170 | 176 | 7 | GO:1902911 | |
| GeneOntologyCellularComponent | centriolar satellite | 7.60e-04 | 128 | 176 | 6 | GO:0034451 | |
| GeneOntologyCellularComponent | lamellipodium membrane | 8.03e-04 | 22 | 176 | 3 | GO:0031258 | |
| GeneOntologyCellularComponent | DNA repair complex | 9.18e-04 | 23 | 176 | 3 | GO:1990391 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | ANKRD13D ANKRD13B TRAF6 STK26 TRAIP APC2 CPD SPAG9 UPF1 AXIN1 MAGI2 RASIP1 RAPGEF3 KCNMA1 PATJ NOS1 FIGNL1 TPD52 | 9.31e-04 | 934 | 176 | 18 | GO:0048471 |
| GeneOntologyCellularComponent | distal axon | CAD SLC4A8 MYO5A DCC ARPC3 PARD6A RAPGEF3 KCNMA1 PRKCB NOS1 CNGB1 | 1.19e-03 | 435 | 176 | 11 | GO:0150034 |
| GeneOntologyCellularComponent | terminal bouton | 1.32e-03 | 96 | 176 | 5 | GO:0043195 | |
| GeneOntologyCellularComponent | glutamatergic synapse | HIP1 TRAF6 SLC4A8 ABL2 MYO5A SYT17 PLXND1 PDE10A MAGI2 DIP2A LZTS1 KCNMA1 SCRIB TACC3 NOS1 TPD52 | 1.52e-03 | 817 | 176 | 16 | GO:0098978 |
| GeneOntologyCellularComponent | axon terminus | 2.06e-03 | 210 | 176 | 7 | GO:0043679 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 2.19e-03 | 335 | 176 | 9 | GO:0061695 | |
| GeneOntologyCellularComponent | postsynapse | HIP1 COL13A1 ABL2 MYO5A SYT17 MINK1 APC2 DCC DNAJC6 MAGI2 DIP2A LZTS1 KCNMA1 PALM SCRIB TACC3 ALDOC NOS1 | 2.41e-03 | 1018 | 176 | 18 | GO:0098794 |
| GeneOntologyCellularComponent | cell surface | PSG1 BTNL8 PSG3 PSG4 PSG6 PSG9 WNT6 DCC TYRO3 DIP2A PTPRK CIITA KCNMA1 ABCB11 SLC39A6 PSG8 LILRB5 NOTCH2 PDCD1LG2 | 2.66e-03 | 1111 | 176 | 19 | GO:0009986 |
| GeneOntologyCellularComponent | extrinsic component of synaptic membrane | 3.15e-03 | 35 | 176 | 3 | GO:0099243 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 2.19e-10 | 17 | 147 | 7 | MP:0031047 | |
| MousePheno | decreased fatty acid oxidation | 3.67e-09 | 24 | 147 | 7 | MP:0014172 | |
| MousePheno | decreased muscle cell glucose uptake | 5.77e-09 | 39 | 147 | 8 | MP:0030022 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 1.21e-08 | 28 | 147 | 7 | MP:0020950 | |
| MousePheno | increased skeletal muscle triglyceride level | 5.82e-08 | 21 | 147 | 6 | MP:0031415 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 6.48e-08 | 35 | 147 | 7 | MP:0031618 | |
| MousePheno | abnormal vascular wound healing | 6.74e-08 | 73 | 147 | 9 | MP:0004883 | |
| MousePheno | decreased cellular glucose uptake | 7.34e-08 | 53 | 147 | 8 | MP:0003926 | |
| MousePheno | increased triglyceride level | CEBPA PSG1 PSG3 PSG4 PSG6 PSG9 SIK3 NXN MSTO1 RAPGEF3 SIK2 PSG8 SCRIB KIF18B ALDOC NOS1 NOS3 | 1.86e-07 | 354 | 147 | 17 | MP:0005317 |
| MousePheno | abnormal circulating leptin level | CEBPA PSG1 PSG3 PSG4 PSG6 PSG9 BBS1 SIK3 PDE10A BBS10 RAPGEF3 PSG8 ATM NOS3 | 1.90e-07 | 236 | 147 | 14 | MP:0005667 |
| MousePheno | increased abdominal fat pad weight | 3.01e-07 | 27 | 147 | 6 | MP:0009286 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 3.41e-07 | 44 | 147 | 7 | MP:0031023 | |
| MousePheno | abnormal muscle cell glucose uptake | 4.77e-07 | 67 | 147 | 8 | MP:0004130 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 5.45e-07 | 47 | 147 | 7 | MP:0031617 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 7.24e-07 | 31 | 147 | 6 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 7.24e-07 | 31 | 147 | 6 | MP:0008964 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 7.31e-07 | 49 | 147 | 7 | MP:0020948 | |
| MousePheno | abnormal fatty acid oxidation | 1.44e-06 | 54 | 147 | 7 | MP:0010953 | |
| MousePheno | abnormal muscle triglyceride level | 1.83e-06 | 36 | 147 | 6 | MP:0031412 | |
| MousePheno | abnormal respiratory quotient | 2.77e-06 | 178 | 147 | 11 | MP:0004129 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 2.99e-06 | 60 | 147 | 7 | MP:0009790 | |
| MousePheno | abnormal lipid oxidation | 3.34e-06 | 61 | 147 | 7 | MP:0010951 | |
| MousePheno | decreased energy expenditure | 4.46e-06 | 119 | 147 | 9 | MP:0004890 | |
| MousePheno | abnormal wound healing | 6.04e-06 | 193 | 147 | 11 | MP:0005023 | |
| MousePheno | abnormal carbon dioxide production | 6.32e-06 | 67 | 147 | 7 | MP:0008962 | |
| MousePheno | increased circulating leptin level | 6.68e-06 | 125 | 147 | 9 | MP:0005669 | |
| MousePheno | insulin resistance | 7.34e-06 | 197 | 147 | 11 | MP:0005331 | |
| MousePheno | abnormal circulating triglyceride level | CEBPA PSG1 PSG3 PSG4 PSG6 PSG9 SIK3 NXN MSTO1 RAPGEF3 SIK2 ABCB11 PSG8 SCRIB KIF18B ALDOC NOS1 NOS3 | 7.90e-06 | 516 | 147 | 18 | MP:0011969 |
| MousePheno | abnormal cellular glucose uptake | 1.18e-05 | 102 | 147 | 8 | MP:0003925 | |
| MousePheno | decreased respiratory quotient | 2.05e-05 | 110 | 147 | 8 | MP:0010379 | |
| MousePheno | polyphagia | 2.06e-05 | 80 | 147 | 7 | MP:0001433 | |
| MousePheno | decreased susceptibility to Riboviria infection | 2.42e-05 | 82 | 147 | 7 | MP:0020914 | |
| MousePheno | obese | 2.49e-05 | 113 | 147 | 8 | MP:0001261 | |
| MousePheno | increased food intake | 3.08e-05 | 189 | 147 | 10 | MP:0011939 | |
| MousePheno | increased insulin secretion | 5.54e-05 | 64 | 147 | 6 | MP:0003058 | |
| MousePheno | ovary degeneration | 9.14e-05 | 9 | 147 | 3 | MP:0013236 | |
| MousePheno | decreased cell proliferation | TRAF6 CEBPA WNT6 AHCTF1 TRAIP PARG TERT DENND1A BRCA2 CIITA LZTS1 PRMT5 NUS1 PRKCB ATM TAF4B FYB1 NOS3 NOTCH2 PDCD1LG2 | 9.30e-05 | 739 | 147 | 20 | MP:0000352 |
| MousePheno | increased circulating triglyceride level | CEBPA SIK3 NXN MSTO1 RAPGEF3 SIK2 SCRIB KIF18B ALDOC NOS1 NOS3 | 1.02e-04 | 262 | 147 | 11 | MP:0001552 |
| MousePheno | reversion by viral sequence excision | 1.10e-04 | 2 | 147 | 2 | MP:0003176 | |
| MousePheno | abnormal cerebral blood flow rate | 1.10e-04 | 2 | 147 | 2 | MP:0031182 | |
| MousePheno | abnormal energy expenditure | CEBPA PSG1 PSG3 PSG4 PSG6 PSG9 SIK3 PDE10A DIP2A RAPGEF3 SIK2 PSG8 | 1.16e-04 | 313 | 147 | 12 | MP:0005450 |
| MousePheno | abnormal fat pad morphology | CEBPA PSG1 PSG3 PSG4 PSG6 PSG9 BBS1 SIK3 PDE10A RAPGEF3 PSG8 NOS3 | 1.20e-04 | 314 | 147 | 12 | MP:0005334 |
| MousePheno | increased incidence of tumors by chemical induction | 1.20e-04 | 141 | 147 | 8 | MP:0004499 | |
| MousePheno | abnormal incidence of induced tumors | 1.28e-04 | 269 | 147 | 11 | MP:0013151 | |
| MousePheno | abnormal triglyceride level | CEBPA PSG1 PSG3 PSG4 PSG6 PSG9 SIK3 NXN MSTO1 RAPGEF3 SIK2 ABCB11 PSG8 SCRIB KIF18B ALDOC NOS1 NOS3 | 1.30e-04 | 639 | 147 | 18 | MP:0000187 |
| MousePheno | abnormal glycogen homeostasis | 1.39e-04 | 144 | 147 | 8 | MP:0005438 | |
| MousePheno | abnormal energy homeostasis | CEBPA PSG1 PSG3 PSG4 PSG6 PSG9 SIK3 PDE10A DIP2A RAPGEF3 SIK2 PSG8 | 1.51e-04 | 322 | 147 | 12 | MP:0005448 |
| MousePheno | decreased oxygen consumption | 1.81e-04 | 79 | 147 | 6 | MP:0005290 | |
| MousePheno | abnormal intestine morphology | TRAF6 TTLL3 PSG1 PSG3 PSG4 PSG6 PSG9 STK26 DCC NXN TERT AXIN1 UGGT2 PSG8 NOS1 FOXP3 | 2.02e-04 | 546 | 147 | 16 | MP:0000477 |
| MousePheno | abnormal eating behavior | CEBPA PSG1 PSG3 FEZF2 PSG4 PSG6 PSG9 BBS1 SIK3 DCC PDE10A BBS10 TGM1 RAPGEF3 SIK2 PSG8 ATM | 2.05e-04 | 604 | 147 | 17 | MP:0001431 |
| MousePheno | increased CD8-positive, alpha-beta T cell number | 2.18e-04 | 195 | 147 | 9 | MP:0008078 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 2.19e-04 | 286 | 147 | 11 | MP:0008873 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 2.72e-04 | 120 | 147 | 7 | MP:0009786 | |
| MousePheno | abnormal brain blood flow rate | 3.27e-04 | 3 | 147 | 2 | MP:0031179 | |
| MousePheno | decreased susceptibility to viral infection | 3.49e-04 | 125 | 147 | 7 | MP:0002410 | |
| MousePheno | abnormal consumption behavior | CEBPA PSG1 PSG3 FEZF2 PSG4 PSG6 PSG9 BBS1 SIK3 DCC PDE10A BBS10 TGM1 RAPGEF3 SIK2 PSG8 ATM NOS1 | 3.65e-04 | 695 | 147 | 18 | MP:0002069 |
| MousePheno | abnormal tumor incidence | CEBPA TTLL3 PSG1 PSG3 PSG4 PSG6 PSG9 DCC TERT FANCD2 BRCA2 LZTS1 PSG8 ATM SCRIB MOS PLCE1 | 3.67e-04 | 635 | 147 | 17 | MP:0002019 |
| MousePheno | abnormal abdominal fat pad morphology | 4.51e-04 | 262 | 147 | 10 | MP:0000010 | |
| MousePheno | increased tumor incidence | CEBPA TTLL3 PSG1 PSG3 PSG4 PSG6 PSG9 DCC FANCD2 BRCA2 LZTS1 PSG8 ATM SCRIB MOS | 4.65e-04 | 530 | 147 | 15 | MP:0002020 |
| MousePheno | abnormal tumor susceptibility | CEBPA TTLL3 PSG1 PSG3 PSG4 PSG6 PSG9 DCC TERT FANCD2 BRCA2 LZTS1 PSG8 ATM SCRIB MOS PLCE1 | 4.79e-04 | 650 | 147 | 17 | MP:0002166 |
| MousePheno | increased incidence of induced tumors | 4.85e-04 | 173 | 147 | 8 | MP:0002021 | |
| MousePheno | impaired glucose tolerance | CEBPA PSG1 PSG3 PSG4 PSG6 PSG9 CPD PARD6A RAPGEF3 SIK2 PALM PSG8 ATM DHX29 | 5.37e-04 | 480 | 147 | 14 | MP:0005293 |
| MousePheno | abnormal food intake | CEBPA PSG1 PSG3 PSG4 PSG6 PSG9 BBS1 PDE10A BBS10 TGM1 RAPGEF3 SIK2 PSG8 ATM | 5.49e-04 | 481 | 147 | 14 | MP:0005449 |
| MousePheno | abnormal adiponectin level | 5.97e-04 | 65 | 147 | 5 | MP:0004891 | |
| MousePheno | abnormal primary polar body morphology | 6.50e-04 | 4 | 147 | 2 | MP:0012737 | |
| MousePheno | decreased coronary flow rate | 6.50e-04 | 4 | 147 | 2 | MP:0003023 | |
| MousePheno | decreased adiponectin level | 6.56e-04 | 38 | 147 | 4 | MP:0004893 | |
| MousePheno | abnormal dendritic cell morphology | 7.83e-04 | 143 | 147 | 7 | MP:0005461 | |
| MousePheno | impaired humoral immune response | 7.99e-04 | 40 | 147 | 4 | MP:0020154 | |
| MousePheno | neoplasm | CEBPA TTLL3 PSG1 PSG3 PSG4 PSG6 PSG9 DCC TERT FANCD2 BRCA2 LZTS1 PSG8 ATM SCRIB MOS PLCE1 PDCD1LG2 | 8.51e-04 | 747 | 147 | 18 | MP:0002006 |
| MousePheno | increased CD4-positive, alpha-beta T cell number | 1.01e-03 | 241 | 147 | 9 | MP:0008074 | |
| MousePheno | abnormal oxygen consumption | 1.06e-03 | 195 | 147 | 8 | MP:0005288 | |
| MousePheno | abnormal bile canaliculus morphology | 1.08e-03 | 5 | 147 | 2 | MP:0008991 | |
| MousePheno | intrahepatic cholestasis | 1.08e-03 | 5 | 147 | 2 | MP:0005415 | |
| MousePheno | abnormal colon morphology | 1.12e-03 | 152 | 147 | 7 | MP:0000495 | |
| Domain | IGc2 | MYOT PSG1 PSG3 PSG4 PSG6 PSG9 SPEG DCC TYRO3 IGSF9 PSG8 FGFR4 LILRB5 | 3.02e-07 | 235 | 173 | 13 | SM00408 |
| Domain | Ig_sub2 | MYOT PSG1 PSG3 PSG4 PSG6 PSG9 SPEG DCC TYRO3 IGSF9 PSG8 FGFR4 LILRB5 | 3.02e-07 | 235 | 173 | 13 | IPR003598 |
| Domain | IG | MYOT PSG1 BTNL8 PSG3 PSG4 PSG6 PSG9 SPEG DCC TYRO3 PTPRK IGSF9 PSG8 FGFR4 LILRB5 PDCD1LG2 | 1.99e-06 | 421 | 173 | 16 | SM00409 |
| Domain | Ig_sub | MYOT PSG1 BTNL8 PSG3 PSG4 PSG6 PSG9 SPEG DCC TYRO3 PTPRK IGSF9 PSG8 FGFR4 LILRB5 PDCD1LG2 | 1.99e-06 | 421 | 173 | 16 | IPR003599 |
| Domain | Ig_2 | 5.05e-06 | 73 | 173 | 7 | PF13895 | |
| Domain | ig | 1.13e-05 | 190 | 173 | 10 | PF00047 | |
| Domain | Immunoglobulin | 1.13e-05 | 190 | 173 | 10 | IPR013151 | |
| Domain | - | MYOT PSG1 MYCBP2 BTNL8 PSG3 PSG4 PSG6 PSG9 SPEG PLXND1 DCC TYRO3 TGM1 PTPRK IGSF9 PSG8 FGFR4 LILRB5 PDCD1LG2 | 1.31e-05 | 663 | 173 | 19 | 2.60.40.10 |
| Domain | IG_LIKE | MYOT PSG1 BTNL8 PSG3 PSG4 PSG6 PSG9 SPEG DCC TYRO3 PTPRK IGSF9 PSG8 FGFR4 LILRB5 PDCD1LG2 | 1.39e-05 | 491 | 173 | 16 | PS50835 |
| Domain | Ig-like_dom | MYOT PSG1 BTNL8 PSG3 PSG4 PSG6 PSG9 SPEG DCC TYRO3 PTPRK IGSF9 PSG8 FGFR4 LILRB5 PDCD1LG2 | 1.87e-05 | 503 | 173 | 16 | IPR007110 |
| Domain | Ig-like_fold | MYOT PSG1 MYCBP2 BTNL8 PSG3 PSG4 PSG6 PSG9 SPEG PLXND1 DCC TYRO3 TGM1 PTPRK IGSF9 PSG8 FGFR4 LILRB5 PDCD1LG2 | 3.11e-05 | 706 | 173 | 19 | IPR013783 |
| Domain | Protein_kinase_ATP_BS | ABL2 SPEG STK26 MINK1 SIK3 TYRO3 STK10 TESK2 SIK2 PRKCB FGFR4 MOS | 2.22e-04 | 379 | 173 | 12 | IPR017441 |
| Domain | NO_synthase | 2.54e-04 | 3 | 173 | 2 | PF02898 | |
| Domain | NOS_euk | 2.54e-04 | 3 | 173 | 2 | IPR012144 | |
| Domain | - | 2.54e-04 | 3 | 173 | 2 | 3.90.340.10 | |
| Domain | NOS_N | 2.54e-04 | 3 | 173 | 2 | IPR004030 | |
| Domain | NOS | 2.54e-04 | 3 | 173 | 2 | PS60001 | |
| Domain | FAM47 | 5.06e-04 | 4 | 173 | 2 | PF14642 | |
| Domain | GPCR_chapero_1 | 5.06e-04 | 4 | 173 | 2 | PF11904 | |
| Domain | FAM47 | 5.06e-04 | 4 | 173 | 2 | IPR032743 | |
| Domain | ANKRD13 | 5.06e-04 | 4 | 173 | 2 | IPR021832 | |
| Domain | C/EBP_chordates | 5.06e-04 | 4 | 173 | 2 | IPR016468 | |
| Domain | Kinase-like_dom | ABL2 SPEG STK26 MINK1 PLK5 SIK3 TYRO3 STK10 TESK2 SIK2 PRKCB ATM FGFR4 MOS | 5.37e-04 | 542 | 173 | 14 | IPR011009 |
| Domain | Prot_kinase_dom | ABL2 SPEG STK26 MINK1 PLK5 SIK3 TYRO3 STK10 TESK2 SIK2 PRKCB FGFR4 MOS | 6.51e-04 | 489 | 173 | 13 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | ABL2 SPEG STK26 MINK1 PLK5 SIK3 TYRO3 STK10 TESK2 SIK2 PRKCB FGFR4 MOS | 7.01e-04 | 493 | 173 | 13 | PS50011 |
| Domain | C/EBP | 8.38e-04 | 5 | 173 | 2 | IPR031106 | |
| Domain | PROTEIN_KINASE_ATP | ABL2 SPEG STK26 MINK1 SIK3 TYRO3 STK10 TESK2 SIK2 PRKCB FGFR4 MOS | 1.21e-03 | 459 | 173 | 12 | PS00107 |
| Domain | Dilute_dom | 1.25e-03 | 6 | 173 | 2 | IPR002710 | |
| Domain | FAD_binding_1 | 1.25e-03 | 6 | 173 | 2 | PF00667 | |
| Domain | - | 1.25e-03 | 6 | 173 | 2 | 1.20.990.10 | |
| Domain | DIL | 1.25e-03 | 6 | 173 | 2 | PF01843 | |
| Domain | FAD-binding_1 | 1.25e-03 | 6 | 173 | 2 | IPR003097 | |
| Domain | DILUTE | 1.25e-03 | 6 | 173 | 2 | PS51126 | |
| Domain | DIL | 1.25e-03 | 6 | 173 | 2 | SM01132 | |
| Domain | NADPH_Cyt_P450_Rdtase_dom3 | 1.25e-03 | 6 | 173 | 2 | IPR023173 | |
| Domain | ABC_membrane | 1.37e-03 | 24 | 173 | 3 | PF00664 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 7.60e-06 | 188 | 127 | 10 | MM15828 | |
| Pathway | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | 4.05e-05 | 22 | 127 | 4 | M915 | |
| Pathway | WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM | 1.33e-04 | 55 | 127 | 5 | M39598 | |
| Pathway | REACTOME_HEMOSTASIS | PSG1 PSG3 PSG4 PSG6 PSG9 CARMIL1 OLA1 PDE10A PPP2R5E RAPGEF3 PRKCB PSG8 KIF18B NOS1 NOS3 | 1.90e-04 | 571 | 127 | 15 | MM14472 |
| Pathway | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | 1.91e-04 | 13 | 127 | 3 | MM15015 | |
| Pathway | WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS | 1.91e-04 | 13 | 127 | 3 | M39894 | |
| Pubmed | 2.72e-13 | 14 | 178 | 7 | 1648219 | ||
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 2.75e-11 | 13 | 178 | 6 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 2.75e-11 | 13 | 178 | 6 | 19273835 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 20044046 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 32150576 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 6265583 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 2.75e-11 | 13 | 178 | 6 | 12832451 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 25406283 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 8380065 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 1279194 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 25724769 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 2.75e-11 | 13 | 178 | 6 | 22092845 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 2.75e-11 | 13 | 178 | 6 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 2.75e-11 | 13 | 178 | 6 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 2.75e-11 | 13 | 178 | 6 | 23800882 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 19285068 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 2.75e-11 | 13 | 178 | 6 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 2.75e-11 | 13 | 178 | 6 | 39168268 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 8402684 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 2.75e-11 | 13 | 178 | 6 | 21949477 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 26219866 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 2133556 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 19621080 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 2.75e-11 | 13 | 178 | 6 | 19358828 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 16680193 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 2.75e-11 | 13 | 178 | 6 | 34058224 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 10964771 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 2.75e-11 | 13 | 178 | 6 | 23935487 | |
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 2.75e-11 | 13 | 178 | 6 | 25972571 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 2.75e-11 | 13 | 178 | 6 | 15220458 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 18843289 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 15207636 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 21081647 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 11133662 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 11483763 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 18003729 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 20739537 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 2.75e-11 | 13 | 178 | 6 | 27695943 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 20404914 | ||
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 2.75e-11 | 13 | 178 | 6 | 16638824 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 34440862 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 2.75e-11 | 13 | 178 | 6 | 21670291 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 22162753 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 2702644 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 11801635 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 21760897 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 1719235 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 16619040 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 2.75e-11 | 13 | 178 | 6 | 8209741 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 32521208 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 19406938 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 2.75e-11 | 13 | 178 | 6 | 29967450 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 1653760 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 32169849 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 2.75e-11 | 13 | 178 | 6 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 2.75e-11 | 13 | 178 | 6 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 2.75e-11 | 13 | 178 | 6 | 15316023 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 15331748 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 2.75e-11 | 13 | 178 | 6 | 22406619 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 7628460 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 19008452 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 2164599 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 29396368 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 2.75e-11 | 13 | 178 | 6 | 33352461 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 38381498 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 1633107 | ||
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 2.75e-11 | 13 | 178 | 6 | 32027621 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 2.75e-11 | 13 | 178 | 6 | 27777319 | |
| Pubmed | 2.75e-11 | 13 | 178 | 6 | 18848945 | ||
| Pubmed | 4.79e-11 | 14 | 178 | 6 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 4.79e-11 | 14 | 178 | 6 | 34666041 | |
| Pubmed | 4.79e-11 | 14 | 178 | 6 | 34619794 | ||
| Pubmed | 4.79e-11 | 14 | 178 | 6 | 8896983 | ||
| Pubmed | 4.79e-11 | 14 | 178 | 6 | 22962327 | ||
| Pubmed | 4.79e-11 | 14 | 178 | 6 | 17623671 | ||
| Pubmed | 4.79e-11 | 14 | 178 | 6 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 4.79e-11 | 14 | 178 | 6 | 18794798 | |
| Pubmed | 4.79e-11 | 14 | 178 | 6 | 23469261 | ||
| Pubmed | 4.79e-11 | 14 | 178 | 6 | 18454175 | ||
| Pubmed | 4.79e-11 | 14 | 178 | 6 | 29907459 | ||
| Pubmed | 4.79e-11 | 14 | 178 | 6 | 36719377 | ||
| Pubmed | 4.79e-11 | 14 | 178 | 6 | 28567513 | ||
| Pubmed | 4.79e-11 | 14 | 178 | 6 | 8207827 | ||
| Pubmed | 4.79e-11 | 14 | 178 | 6 | 19700760 | ||
| Pubmed | 4.79e-11 | 14 | 178 | 6 | 9212243 | ||
| Pubmed | 4.79e-11 | 14 | 178 | 6 | 14517298 | ||
| Pubmed | 4.79e-11 | 14 | 178 | 6 | 25908210 | ||
| Pubmed | 4.79e-11 | 14 | 178 | 6 | 9047385 | ||
| Pubmed | Ceacam1L Modulates STAT3 Signaling to Control the Proliferation of Glioblastoma-Initiating Cells. | 4.79e-11 | 14 | 178 | 6 | 26238781 | |
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 4.79e-11 | 14 | 178 | 6 | 17081782 | |
| Interaction | PSG4 interactions | 3.66e-07 | 8 | 174 | 4 | int:PSG4 | |
| Interaction | LIG1 interactions | 1.50e-06 | 126 | 174 | 9 | int:LIG1 | |
| Interaction | PSG1 interactions | 4.96e-06 | 51 | 174 | 6 | int:PSG1 | |
| Interaction | PTPA interactions | 7.09e-06 | 115 | 174 | 8 | int:PTPA | |
| Interaction | PTGES3 interactions | USP36 CAD MINK1 BBS1 SIK3 TERT ZSWIM9 DIP2A BRCA2 LMBR1L KIF18B SNRNP200 MOV10 TPD52 | 2.76e-05 | 437 | 174 | 14 | int:PTGES3 |
| Cytoband | 19q13.2 | 4.63e-05 | 164 | 178 | 6 | 19q13.2 | |
| Cytoband | 2q35 | 2.62e-04 | 79 | 178 | 4 | 2q35 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 2.48e-11 | 11 | 114 | 6 | 1315 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 7.80e-05 | 163 | 114 | 7 | 590 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.49e-04 | 161 | 114 | 6 | 593 | |
| GeneFamily | Basic leucine zipper proteins|CCAAT/enhancer binding proteins | 5.81e-04 | 6 | 114 | 2 | 1165 | |
| GeneFamily | UPF1 like RNA helicases | 2.09e-03 | 11 | 114 | 2 | 1169 | |
| GeneFamily | ATP binding cassette subfamily B | 2.09e-03 | 11 | 114 | 2 | 806 | |
| GeneFamily | PDZ domain containing | 2.77e-03 | 152 | 114 | 5 | 1220 | |
| GeneFamily | Tubulin tyrosine ligase family | 3.41e-03 | 14 | 114 | 2 | 779 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 3.92e-03 | 15 | 114 | 2 | 696 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 6.82e-08 | 32 | 177 | 6 | MM2 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | ABCC3 COL16A1 PSG1 PSG3 PSG4 PSG6 PSG9 NXN PTPRK SLC39A6 PSG8 PATJ ALDOC | 7.58e-08 | 284 | 177 | 13 | MM987 |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 1.20e-07 | 35 | 177 | 6 | MM757 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 3.59e-07 | 135 | 177 | 9 | MM965 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 7.67e-07 | 75 | 177 | 7 | MM605 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 8.45e-07 | 48 | 177 | 6 | MM531 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 1.42e-06 | 159 | 177 | 9 | MM760 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 4.33e-06 | 182 | 177 | 9 | MM993 | |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | 5.39e-06 | 187 | 177 | 9 | M6807 | |
| Coexpression | GSE30971_WBP7_HET_VS_KO_MACROPHAGE_UP | 9.28e-06 | 200 | 177 | 9 | M8698 | |
| Coexpression | GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP | 9.28e-06 | 200 | 177 | 9 | M6842 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 9.66e-06 | 201 | 177 | 9 | MM1006 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | USP36 KLF11 TRAF6 ABL2 PSG1 PSG4 PSG6 PSG9 ABHD3 YRDC SPAG9 HS1BP3 SIK3 PDE10A AXIN1 STK10 PRDM10 LMBR1L | 1.25e-05 | 822 | 177 | 18 | M6782 |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 1.91e-05 | 219 | 177 | 9 | MM3826 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 2.80e-05 | 87 | 177 | 6 | MM851 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP | 2.81e-05 | 230 | 177 | 9 | MM986 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 4.08e-05 | 93 | 177 | 6 | M40279 | |
| Coexpression | GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN | 6.53e-05 | 199 | 177 | 8 | M3460 | |
| Coexpression | GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_DN | 6.53e-05 | 199 | 177 | 8 | M7976 | |
| Coexpression | GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP | 6.77e-05 | 200 | 177 | 8 | M9391 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_DN | 6.77e-05 | 200 | 177 | 8 | M3893 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_UP | 6.77e-05 | 200 | 177 | 8 | M7954 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 6.77e-05 | 200 | 177 | 8 | M5901 | |
| Coexpression | GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP | 6.77e-05 | 200 | 177 | 8 | M6539 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 6.86e-05 | 102 | 177 | 6 | M10290 | |
| Coexpression | GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN | 1.94e-04 | 175 | 177 | 7 | M8667 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_DN | RNF130 PSG1 PSG3 PSG4 PSG6 PSG9 STAP2 EVPL DENND11 PSG8 TPD52 | 1.96e-04 | 436 | 177 | 11 | MM1326 |
| Coexpression | GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 2.01e-04 | 176 | 177 | 7 | M9137 | |
| Coexpression | HUMMEL_BURKITTS_LYMPHOMA_UP | 2.02e-04 | 43 | 177 | 4 | M3134 | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 1.04e-07 | 198 | 177 | 9 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-07 | 155 | 177 | 8 | 59035d792c26d870a8b097939e97fa47859ba68c | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.17e-07 | 164 | 177 | 8 | 0662cd9d21608efacc336e0a582859f3b9a4951d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-07 | 165 | 177 | 8 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.42e-07 | 176 | 177 | 8 | 581045e61cdcdfa85701343d1a7c0a72a36606a7 | |
| ToppCell | Control-T_cells-NK_cells|Control / group, cell type (main and fine annotations) | 7.91e-07 | 185 | 177 | 8 | 755c0998c729f462399f1d5e88adf4bfae31be30 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-06 | 192 | 177 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.09e-06 | 193 | 177 | 8 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | 1.13e-06 | 194 | 177 | 8 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d | |
| ToppCell | Adult-Immune-monocyte|Adult / Lineage, Cell type, age group and donor | 1.22e-06 | 196 | 177 | 8 | 3ef193c5180de3137daf886492e74fc574bc9767 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.22e-06 | 196 | 177 | 8 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-06 | 197 | 177 | 8 | 76b61e60a757e58b465569538e632d6d9953e89a | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 1.27e-06 | 197 | 177 | 8 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 197 | 177 | 8 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 1.32e-06 | 198 | 177 | 8 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 1.32e-06 | 198 | 177 | 8 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-06 | 156 | 177 | 7 | b3f10cd044f24807576e7d56e51df7064dbf6c50 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-CD163+_Macrophage|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.64e-06 | 160 | 177 | 7 | 4480a7d6bd48d06b4e5196faac868f31ab7ed3ad | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.79e-06 | 161 | 177 | 7 | ebcd5066e82b7760b9da6adc02d11258d1309dab | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.11e-06 | 163 | 177 | 7 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-06 | 169 | 177 | 7 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | facs-Heart-LV-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-06 | 170 | 177 | 7 | 60041b2e57e958f300a5bc76851705c8baf297c2 | |
| ToppCell | facs-Heart-LV-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-06 | 170 | 177 | 7 | 4eaa22040e475100061475123aefa32b56481464 | |
| ToppCell | facs-Heart-LV-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-06 | 170 | 177 | 7 | 793dde64f5517538b66de5f461a445c4ad6dd7b3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.64e-06 | 171 | 177 | 7 | 55c7bf7211587fa08df13c0a4ff5b78a85d5439e | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.09e-06 | 173 | 177 | 7 | ad9777e4ae70b11676ec735eb6db91776ca0cb19 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.32e-06 | 174 | 177 | 7 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.07e-06 | 177 | 177 | 7 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.61e-06 | 179 | 177 | 7 | 8a66d197a2f55d763ff7ef0bec89ee96f59c3937 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.61e-06 | 179 | 177 | 7 | d4efbc34f52136039b96451fd0b0a0ad164197c6 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.61e-06 | 179 | 177 | 7 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-06 | 181 | 177 | 7 | 859c40889ede2cbf374c4d2efbb72dc3bc6441f5 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.48e-06 | 182 | 177 | 7 | 21dcab170ffeef89faa9fee5008568cb6e15c694 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.43e-06 | 185 | 177 | 7 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 9.43e-06 | 185 | 177 | 7 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 9.43e-06 | 185 | 177 | 7 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.43e-06 | 185 | 177 | 7 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-06 | 186 | 177 | 7 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-06 | 186 | 177 | 7 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 187 | 177 | 7 | e53471c3e146a6f54788d81ecc469aba55b051bb | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 187 | 177 | 7 | dbcec24d2c852964736c78e9d81650bff5c455ae | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 1.01e-05 | 187 | 177 | 7 | 5429ae85942b8ec3895cceb63c663de3c24ca064 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 187 | 177 | 7 | 3d7d51fbadb20dc884d0b3c0d61b80f022b19d09 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 187 | 177 | 7 | a2076599b33ae6750961b573bfebcb9036fa4ee8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 187 | 177 | 7 | 38ee33295a21db4aae5ba085df033db9693e41c6 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.05e-05 | 188 | 177 | 7 | 71b7599e7e1d63cc0c8518c0501533755951d58f | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.05e-05 | 188 | 177 | 7 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | Control-Myeloid-Monocytes|Control / group, cell type (main and fine annotations) | 1.08e-05 | 189 | 177 | 7 | 3335d16bd0ffa0c1ddd06d7da645299148130c3f | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-05 | 191 | 177 | 7 | 6345c1aa0fd2f9f2154a44f9393bf7c72bb1f44e | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-05 | 191 | 177 | 7 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | Immune-natural_killer_cell|World / Lineage, Cell type, age group and donor | 1.20e-05 | 192 | 177 | 7 | 68121a6ef4115a93d87aad8802ef9b27d793d8c0 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 1.20e-05 | 192 | 177 | 7 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 1.24e-05 | 193 | 177 | 7 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 1.24e-05 | 193 | 177 | 7 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 1.24e-05 | 193 | 177 | 7 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 1.24e-05 | 193 | 177 | 7 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.24e-05 | 193 | 177 | 7 | 1cb666375bc4e1b11a146d20896c9b5ae6fd0887 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-05 | 194 | 177 | 7 | e237384b02be460d44eeada3026a5691c66f6fc1 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-05 | 194 | 177 | 7 | 0bc83ae79873a5e473e6e1e3111924cd003986a1 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-05 | 194 | 177 | 7 | dfe0ece81922bfd7c6673726d3ea2365cbdb5513 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 194 | 177 | 7 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.28e-05 | 194 | 177 | 7 | 663e7e7fe48157e808b4f1a0ea6ad41944e857a2 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.30e-05 | 129 | 177 | 6 | 5e4783cc63afdeaebdfaecb72f95f3efc8d3c4a3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 195 | 177 | 7 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 1.33e-05 | 195 | 177 | 7 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 1.33e-05 | 195 | 177 | 7 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.33e-05 | 195 | 177 | 7 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 195 | 177 | 7 | cad21edd90bf3e2fefdf5773a59cb1a664a69ddd | |
| ToppCell | Adult-Immune-monocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.33e-05 | 195 | 177 | 7 | ea24da6fea1487acb1e56c28c0649858cc0a12bd | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.33e-05 | 195 | 177 | 7 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 196 | 177 | 7 | 9a90dd26e7a43e3fd55e7c5d8354cfa4cdd5a6cc | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 1.37e-05 | 196 | 177 | 7 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.37e-05 | 196 | 177 | 7 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.37e-05 | 196 | 177 | 7 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | distal-Hematologic-Interstitial_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-05 | 196 | 177 | 7 | e4f40274df940e0996c555082f2bb4f99e5b0881 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 196 | 177 | 7 | cbc727b55b6433a701b1a331028a49960fcee6ee | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 196 | 177 | 7 | 04dfef1bd4ebb0e9469ae80024dc177e469a2560 | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.42e-05 | 197 | 177 | 7 | 0b1fa881abbfcc54b322fc27124db3f8947af016 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 197 | 177 | 7 | 488e85991c5e668afb7672942726d9295b8fc7d8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 197 | 177 | 7 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | Children_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.42e-05 | 197 | 177 | 7 | f18807124b91310fcd84238484a80ecdba684679 | |
| ToppCell | background-Kupffer_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.42e-05 | 197 | 177 | 7 | 8b45c7ecc18d188abc8c172d9bf881c95617a46a | |
| ToppCell | nucseq-Immune-Immune_Myeloid-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.42e-05 | 197 | 177 | 7 | 6f41c8f815851968849428ec92c16745bd01a3fb | |
| ToppCell | proximal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.42e-05 | 197 | 177 | 7 | 0dd9058aa19d1268ebba9a65555870224b5a5978 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-IM-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.42e-05 | 197 | 177 | 7 | 304044ace926943b8eb588f686ecbe5d1689a809 | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.42e-05 | 197 | 177 | 7 | 9243617b307acf3df40d93c41cd8d4788699a7ea | |
| ToppCell | distal-Hematologic-Interstitial_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.46e-05 | 198 | 177 | 7 | a35b43d38e18c6f8f0cd9015b8e23f71c729f023 | |
| ToppCell | distal-1-Hematologic-Proliferating_Macrophage|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.46e-05 | 198 | 177 | 7 | df3f5559ecd1f3cd1fd60e39dbad8741309e83a3 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.46e-05 | 198 | 177 | 7 | 8afeb1f9bc9d8551482c8fefe4c5f88d9cd13ee2 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.46e-05 | 198 | 177 | 7 | 2b0716e900bce54ad1825d6dcdaf4ebf31f355c4 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_dorsal_progenitors|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.46e-05 | 198 | 177 | 7 | dada1c19a261c8e1090957cd7e37f2a43a9fe14f | |
| ToppCell | cycling_basal_cell|World / shred by cell class for turbinate | 1.46e-05 | 198 | 177 | 7 | e86c1224f5b0890a50a25257628e90c790aae7cd | |
| ToppCell | (0)_NK_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.46e-05 | 198 | 177 | 7 | 5ebb4965b723302152b42bfaf48bb77a57dd02c5 | |
| ToppCell | Immune|World / Lineage, Cell type, age group and donor | 1.46e-05 | 198 | 177 | 7 | 65681b54d13c6997bd90a1c2a12314a80e964fe3 | |
| ToppCell | Healthy_donor-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.46e-05 | 198 | 177 | 7 | 8a97c8b2a43e6d1e669ce18752841e2006744bd9 | |
| ToppCell | proximal-3-Epithelial-Proliferating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.51e-05 | 199 | 177 | 7 | 2263bb73d9c5693b44d91d2548305efc1b6e4079 | |
| ToppCell | Dividing_Macrophages|World / lung cells shred on cell class, cell subclass, sample id | 1.51e-05 | 199 | 177 | 7 | 5c755b6876e164dc847ef7c723f850f227cf3a87 | |
| ToppCell | COVID-19-kidney-Glomerular_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.51e-05 | 199 | 177 | 7 | fffd2f9042b55531dac4e5b463b5cee80402e7bb | |
| ToppCell | proximal-Epithelial-Proliferating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.51e-05 | 199 | 177 | 7 | 521ff4ae3437c8ba477a0a42b9da195af976c3ff | |
| ToppCell | proximal-Epithelial-Proliferating_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.51e-05 | 199 | 177 | 7 | e8549b2c4152cb23548351d9cee27c3805892cd8 | |
| Computational | Neighborhood of EGFR | 1.66e-05 | 32 | 110 | 5 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 2.60e-05 | 35 | 110 | 5 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 6.45e-05 | 42 | 110 | 5 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 1.01e-04 | 46 | 110 | 5 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 1.36e-04 | 49 | 110 | 5 | GNF2_KISS1 | |
| Computational | Neighborhood of CDKN1C | 1.52e-04 | 27 | 110 | 4 | GNF2_CDKN1C | |
| Drug | AC1L1IPV | 8.81e-07 | 43 | 174 | 6 | CID000004683 | |
| Drug | 1-TRIM | 9.27e-06 | 18 | 174 | 4 | CID000001359 | |
| Drug | Rgd Peptide | 1.61e-05 | 239 | 174 | 10 | CID000104802 | |
| Drug | Sulindac [38194-50-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 2.00e-05 | 195 | 174 | 9 | 1815_UP | |
| Drug | Oxolinic acid [14698-29-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 2.08e-05 | 196 | 174 | 9 | 5519_DN | |
| Drug | Arecoline hydrobromide [300-08-3]; Up 200; 17uM; MCF7; HT_HG-U133A | 2.16e-05 | 197 | 174 | 9 | 2657_UP | |
| Drug | Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; PC3; HT_HG-U133A | 2.25e-05 | 198 | 174 | 9 | 4654_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.25e-05 | 198 | 174 | 9 | 3423_DN | |
| Drug | Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.25e-05 | 198 | 174 | 9 | 6838_DN | |
| Disease | cD177 antigen measurement | 5.42e-08 | 18 | 174 | 5 | EFO_0021866 | |
| Disease | sphingomyelin measurement | 4.33e-05 | 278 | 174 | 9 | EFO_0010118 | |
| Disease | Liver carcinoma | CEBPA TROAP TRAIP DNAJC6 TERT AXIN1 FANCD2 KBTBD11 ATM TACC3 KIF18B LILRB5 | 5.14e-05 | 507 | 174 | 12 | C2239176 |
| Disease | Intestinal Perforation | 1.03e-04 | 3 | 174 | 2 | C0021845 | |
| Disease | Gastric Adenocarcinoma | 1.44e-04 | 45 | 174 | 4 | C0278701 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.44e-04 | 45 | 174 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | Malignant neoplasm of urinary bladder | 1.96e-04 | 141 | 174 | 6 | C0005684 | |
| Disease | cancer (implicated_via_orthology) | 2.02e-04 | 268 | 174 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | pregnancy-specific beta-1-glycoprotein 9 measurement | 2.06e-04 | 4 | 174 | 2 | EFO_0801909 | |
| Disease | Adenocarcinoma of prostate | 2.13e-04 | 20 | 174 | 3 | C0007112 | |
| Disease | Colorectal Neoplasms | 2.52e-04 | 277 | 174 | 8 | C0009404 | |
| Disease | Colorectal Carcinoma | DPAGT1 ABCC3 CAD MYOT TTLL3 EFS APC2 DCC NXN KLF2 ABCB11 PRKCB SNRNP200 | 2.87e-04 | 702 | 174 | 13 | C0009402 |
| Disease | Prostatic Neoplasms | RNF130 SLC26A4 TERT BRCA2 PTPRK LZTS1 CHD6 ATM FGFR4 PATJ NOS3 TPD52 | 3.13e-04 | 616 | 174 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | RNF130 SLC26A4 TERT BRCA2 PTPRK LZTS1 CHD6 ATM FGFR4 PATJ NOS3 TPD52 | 3.13e-04 | 616 | 174 | 12 | C0376358 |
| Disease | ESOPHAGEAL CANCER | 3.42e-04 | 5 | 174 | 2 | 133239 | |
| Disease | hypertension, pregnancy-induced | 3.42e-04 | 5 | 174 | 2 | MONDO_0024664 | |
| Disease | Malignant tumor of esophagus | 3.42e-04 | 5 | 174 | 2 | cv:C0546837 | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 3.72e-04 | 24 | 174 | 3 | DOID:3907 (is_implicated_in) | |
| Disease | epilepsy (implicated_via_orthology) | 4.26e-04 | 163 | 174 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 5.11e-04 | 6 | 174 | 2 | EFO_0801907 | |
| Disease | Benign neoplasm of esophagus | 5.11e-04 | 6 | 174 | 2 | C0153942 | |
| Disease | bronchiolitis obliterans (biomarker_via_orthology) | 5.11e-04 | 6 | 174 | 2 | DOID:2799 (biomarker_via_orthology) | |
| Disease | Carcinoma in situ of esophagus | 5.11e-04 | 6 | 174 | 2 | C0154059 | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 5.63e-04 | 64 | 174 | 4 | DOID:224 (implicated_via_orthology) | |
| Disease | neuroimaging measurement | PSG1 EFS CARMIL1 SLC13A3 PLXND1 DCC IDUA PNKD ATP13A2 DENND1A RAB3GAP2 IGSF9 TACC3 KIF18B QSOX2 PLCE1 | 6.21e-04 | 1069 | 174 | 16 | EFO_0004346 |
| Disease | diastolic blood pressure, alcohol drinking | 6.88e-04 | 118 | 174 | 5 | EFO_0004329, EFO_0006336 | |
| Disease | melanoma | 7.03e-04 | 248 | 174 | 7 | C0025202 | |
| Disease | Esophageal carcinoma | 7.12e-04 | 7 | 174 | 2 | C0152018 | |
| Disease | infertility (implicated_via_orthology) | 7.12e-04 | 7 | 174 | 2 | DOID:5223 (implicated_via_orthology) | |
| Disease | mean arterial pressure | USP36 CYP26A1 PDE10A ZNF831 NXN TERT KCNMA1 NOS3 MOV10 PLCE1 | 8.00e-04 | 499 | 174 | 10 | EFO_0006340 |
| Disease | Age-related nuclear cataract | 8.02e-04 | 31 | 174 | 3 | HP_0011142 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 9.75e-04 | 74 | 174 | 4 | DOID:3748 (is_marker_for) | |
| Disease | Parkinson's disease (is_implicated_in) | 1.08e-03 | 76 | 174 | 4 | DOID:14330 (is_implicated_in) | |
| Disease | non-high density lipoprotein cholesterol measurement | SLC4A8 CEBPA PSG1 PSG3 CARMIL1 CYP26A1 BBS1 PNKD BRCA2 ABCB11 QSOX2 PLCE1 | 1.13e-03 | 713 | 174 | 12 | EFO_0005689 |
| Disease | Esophageal Neoplasms | 1.19e-03 | 78 | 174 | 4 | C0014859 | |
| Disease | preeclampsia | 1.19e-03 | 78 | 174 | 4 | EFO_0000668 | |
| Disease | Malignant neoplasm of esophagus | 1.19e-03 | 78 | 174 | 4 | C0546837 | |
| Disease | Bladder Neoplasm | 1.48e-03 | 140 | 174 | 5 | C0005695 | |
| Disease | basophil percentage of granulocytes | 1.49e-03 | 83 | 174 | 4 | EFO_0007995 | |
| Disease | Fanconi anemia (is_implicated_in) | 1.51e-03 | 10 | 174 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | lung cancer (is_marker_for) | 1.58e-03 | 39 | 174 | 3 | DOID:1324 (is_marker_for) | |
| Disease | cardiovascular disease | 1.64e-03 | 457 | 174 | 9 | EFO_0000319 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 2.09e-03 | 43 | 174 | 3 | DOID:9261 (is_marker_for) | |
| Disease | liver cirrhosis (is_implicated_in) | 2.09e-03 | 43 | 174 | 3 | DOID:5082 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.14e-03 | 301 | 174 | 7 | DOID:684 (is_marker_for) | |
| Disease | Neurobehavioral Manifestations | 2.19e-03 | 12 | 174 | 2 | C0525041 | |
| Disease | Diabetes Mellitus, Insulin-Dependent | 2.38e-03 | 45 | 174 | 3 | C0011854 | |
| Disease | Malignant neoplasm of kidney | 2.38e-03 | 45 | 174 | 3 | C0740457 | |
| Disease | Adenocarcinoma of large intestine | 2.55e-03 | 96 | 174 | 4 | C1319315 | |
| Disease | esophageal cancer (is_implicated_in) | 2.58e-03 | 13 | 174 | 2 | DOID:5041 (is_implicated_in) | |
| Disease | cardiomyopathy (biomarker_via_orthology) | 2.58e-03 | 13 | 174 | 2 | DOID:0050700 (biomarker_via_orthology) | |
| Disease | end stage renal disease (biomarker_via_orthology) | 2.70e-03 | 47 | 174 | 3 | DOID:783 (biomarker_via_orthology) | |
| Disease | alkaline phosphatase measurement | DCDC2 SLC4A8 CARMIL1 SLC26A4 MINK1 PNKD AK8 AXIN1 RASIP1 MLIP ABCB11 C17orf107 PLCE1 PDCD1LG2 | 2.87e-03 | 1015 | 174 | 14 | EFO_0004533 |
| Disease | Adenoid Cystic Carcinoma | 2.95e-03 | 100 | 174 | 4 | C0010606 | |
| Disease | Bardet-Biedl syndrome (is_implicated_in) | 3.00e-03 | 14 | 174 | 2 | DOID:1935 (is_implicated_in) | |
| Disease | Fanconi anemia | 3.00e-03 | 14 | 174 | 2 | cv:C0015625 | |
| Disease | asthma, body mass index | 3.00e-03 | 14 | 174 | 2 | EFO_0004340, MONDO_0004979 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 3.04e-03 | 49 | 174 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | cholestasis (biomarker_via_orthology) | 3.04e-03 | 49 | 174 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | eosinophil count | CEBPA CEBPE PSG1 MTF2 SYT17 SIK3 PNKD TERT AK8 KLF2 CIITA SIK2 PRKCB IL17RA ATM SNRNP200 NOTCH2 TPD52 | 3.12e-03 | 1488 | 174 | 18 | EFO_0004842 |
| Disease | Bell's palsy | 3.17e-03 | 102 | 174 | 4 | EFO_0007167 | |
| Disease | Medulloblastoma | 3.22e-03 | 50 | 174 | 3 | C0025149 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 3.35e-03 | 169 | 174 | 5 | DOID:3908 (is_marker_for) | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 3.45e-03 | 15 | 174 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 3.45e-03 | 15 | 174 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 3.45e-03 | 15 | 174 | 2 | C0154091 | |
| Disease | Gastro-enteropancreatic neuroendocrine tumor | 3.45e-03 | 15 | 174 | 2 | C2930967 | |
| Disease | ulcerative colitis | 3.86e-03 | 335 | 174 | 7 | EFO_0000729 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 3.89e-03 | 108 | 174 | 4 | DOID:684 (biomarker_via_orthology) | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 3.93e-03 | 16 | 174 | 2 | C0751885 | |
| Disease | response to thioamide, Drug-induced agranulocytosis | 3.93e-03 | 16 | 174 | 2 | EFO_0007633, HP_0012235 | |
| Disease | phosphatidylcholine 38:6 measurement | 3.93e-03 | 16 | 174 | 2 | EFO_0010388 | |
| Disease | preeclampsia, hypertension, pregnancy-induced | 3.93e-03 | 16 | 174 | 2 | EFO_0000668, MONDO_0024664 | |
| Disease | Hepatomegaly | 4.01e-03 | 54 | 174 | 3 | C0019209 | |
| Disease | facial morphology | 4.22e-03 | 55 | 174 | 3 | EFO_0004743 | |
| Disease | sex interaction measurement, inflammatory bowel disease | 4.22e-03 | 55 | 174 | 3 | EFO_0003767, EFO_0008343 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 4.44e-03 | 17 | 174 | 2 | C0751883 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 4.44e-03 | 17 | 174 | 2 | C2936862 | |
| Disease | Acute myeloid leukemia | 4.44e-03 | 17 | 174 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 4.44e-03 | 17 | 174 | 2 | 601626 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 4.48e-03 | 181 | 174 | 5 | DOID:684 (is_implicated_in) | |
| Disease | Beta blocking agent use measurement | 4.71e-03 | 114 | 174 | 4 | EFO_0009929 | |
| Disease | eosinophil percentage of leukocytes | 4.91e-03 | 746 | 174 | 11 | EFO_0007991 | |
| Disease | borna disease (biomarker_via_orthology) | 4.97e-03 | 18 | 174 | 2 | DOID:5154 (biomarker_via_orthology) | |
| Disease | Bone marrow hypocellularity | 4.97e-03 | 18 | 174 | 2 | C1855710 | |
| Disease | Carcinoma of bladder | 4.97e-03 | 18 | 174 | 2 | C0699885 | |
| Disease | Bardet-Biedl syndrome | 4.97e-03 | 18 | 174 | 2 | cv:C0752166 | |
| Disease | adverse effect, response to xenobiotic stimulus | 5.14e-03 | 59 | 174 | 3 | EFO_0009658, GO_0009410 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 5.53e-03 | 19 | 174 | 2 | C0751884 | |
| Disease | portal hypertension (implicated_via_orthology) | 5.53e-03 | 19 | 174 | 2 | DOID:10762 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FRSQGKPIELTPLPL | 36 | Q16537 | |
| LPVPRLQGIPKVTGR | 1186 | O15013 | |
| RLPKLTPPALRAALG | 31 | Q5SZB4 | |
| DFITLRLPPGFPVKI | 396 | Q6ZTN6 | |
| APGQPLRVLKAPLAT | 161 | Q15744 | |
| KLLPRGATALPLRTP | 851 | P42684 | |
| ISVFPRTPPTKIGVF | 396 | Q6UX41 | |
| ALRRTVPPAVPGVTF | 256 | P09972 | |
| PVSGPQAFPKLVRIL | 966 | P33076 | |
| PKGPLILRLGAAPVT | 71 | Q07092 | |
| RPPATVQKLSRFPLA | 401 | P22455 | |
| TVKRYTPARIAPGLP | 781 | Q5H9F3 | |
| GQTLLRPFITSKPPV | 91 | Q8WU67 | |
| VEPAPVRRILKFSAP | 736 | O95342 | |
| DPFRITALRVPILKP | 151 | Q66LE6 | |
| GFERPSPVQLKAIPL | 81 | Q9UHI6 | |
| KRPPQEGRILQSFPL | 36 | Q9NVE4 | |
| FTLPPPGVRKIVLAT | 916 | Q7Z478 | |
| LIRRIIGLSPFVPPQ | 341 | Q8TAM1 | |
| PGVIRPVPVKSRILL | 331 | Q5VWP3 | |
| LRIRVPPVPPNVAFK | 346 | Q9Y483 | |
| PLATRATAPPGVLKI | 136 | Q5U651 | |
| TTLLPRQPLPLGIKV | 191 | O75781 | |
| VTSVLRLKPPPGRNF | 176 | Q9BQ51 | |
| FVTVLAKLFPGRPPV | 356 | Q6ZRP7 | |
| PKAEVRGQVLAPLPL | 66 | Q86XS8 | |
| KPPPIIGRFGTSLKI | 11 | Q9NTK5 | |
| VGLPPPADRLAILKT | 746 | O15381 | |
| VLLGARPRPRKPSFL | 286 | O15438 | |
| IRKERPISLGIFPLP | 196 | O60271 | |
| FITLRLPPGFPVKIE | 406 | Q86YJ7 | |
| PKVEPATPLAVRFGL | 366 | Q9H2M9 | |
| FLLPKISLRGPQADP | 76 | Q5HY64 | |
| RSPAIAAVGPIKQLP | 461 | O75439 | |
| LPPIVTFQLIPKGSI | 2301 | Q04721 | |
| SRSRGILGKFVPPIP | 331 | Q6PIW4 | |
| LAGKARSPLLPVSVP | 1386 | P43146 | |
| LPPGTGIVKRAPLVR | 611 | Q96F46 | |
| AVRPTAFKPVLPRSG | 121 | Q9Y250 | |
| PLQAPGFREKPLFTR | 401 | Q86UL8 | |
| FPKVSILPGTPLSRA | 896 | Q12791 | |
| FSLKARPGLPPGINV | 141 | Q9BZS1 | |
| VRFDKPPLRLPLTGF | 56 | P60608 | |
| AFKSRVGLPAPAPVI | 331 | Q4FZB7 | |
| NTTIVVPKPFRPILG | 146 | Q9H3H5 | |
| NVPRIVILGPPASGK | 56 | Q96MA6 | |
| ILQPLKATPVFRAPG | 456 | Q9Y4D7 | |
| GKRPLSFLLPTVVRP | 536 | Q9UJ14 | |
| VDLLRAGEVPKPFPT | 486 | Q86W56 | |
| KVVTAGAIIPFPLAP | 366 | Q9BUK6 | |
| IFTPPGIKEGKPRLI | 126 | Q9Y233 | |
| LAVSAPKRPRVAPLQ | 836 | Q92817 | |
| AAVLAPLGFTLRKPP | 46 | Q96E22 | |
| PLGFTLRKPPAVGRN | 51 | Q96E22 | |
| SLPFPGVVLKPAASR | 256 | O15117 | |
| AIPPPLGRIFRKVGQ | 86 | Q496M5 | |
| LVPGVSRKPSLLIPQ | 216 | O75023 | |
| KRVLALPGKPPFLTQ | 391 | P05771 | |
| RIPKRTQFGPVEGPL | 226 | Q9NQV6 | |
| RLPSSTLKRPAGPLV | 801 | Q86Y91 | |
| KPPRGRFDVLPLLLQ | 516 | P29475 | |
| GSLVFPRKLQGRPSP | 101 | P29474 | |
| VPREKPLALGVVRPS | 1096 | Q86Y26 | |
| RPSRINGIFPGTPLK | 151 | Q86XN7 | |
| LASGPPPLRLLVQKR | 81 | Q9NPB6 | |
| KTVLQRPLSLIQGPP | 491 | Q92900 | |
| QGKILPTPETVPFRL | 2896 | Q13315 | |
| LPRKRPPVTQAAGAL | 1886 | O95996 | |
| LKGQAFLPLVPEPRR | 531 | Q9NQ11 | |
| PPLPRKVLFVGESDI | 91 | Q53T59 | |
| LITTGRPTKVFVPPF | 2396 | P51587 | |
| LLPIRSQFKGPAPRE | 21 | O15145 | |
| RVPAIPKEPGLRGFL | 2406 | Q8TD26 | |
| GAPALRPLVIKQEPR | 151 | P49715 | |
| RKRILIFSPPPVGVV | 256 | A4D1U4 | |
| AAPPGRLPQKLLLET | 261 | O15169 | |
| PAPKPTLGLVLREAT | 66 | Q6ZR85 | |
| IGLTVLPPPRTIKIA | 971 | Q2V2M9 | |
| STPGPAIRLLYAKRP | 186 | O75061 | |
| PKPLVVQVPTFARRS | 76 | O00257 | |
| AAGPLLPGRPQVKLV | 121 | O75976 | |
| PILFPIKQPITVREG | 581 | O14744 | |
| GIVPANRVKLLPAGP | 56 | O43281 | |
| PPRLFVPHSKRVVVA | 466 | O43281 | |
| KRVPFPIGIAIPFTA | 231 | Q6ZMT9 | |
| KPPGQVTRLRALPLT | 546 | P35475 | |
| PIKQAFRVLSEPIGP | 496 | Q56NI9 | |
| GSKLFPAVPLPDIRS | 71 | Q9Y4F3 | |
| SITIPRPQGRKTPEL | 696 | Q8TEH3 | |
| LPPLTIQLPKQFSRI | 61 | Q14314 | |
| FLLPKISLRGPQADP | 76 | Q5JRC9 | |
| AFLKPPPQLSVGTVR | 301 | O14901 | |
| LAARPVIPQKPRTAS | 1266 | Q5VZK9 | |
| LNPPVPGGFRVALKT | 366 | O43174 | |
| VFRLVSRPKPLSAVP | 1026 | Q8WYP5 | |
| VRLAPPPVIKRRTFQ | 246 | Q5TAT6 | |
| PLLKPGDRVALVFPN | 391 | Q14689 | |
| PRAFFKVPLLVPGLN | 531 | Q8NFJ9 | |
| KPVISITSQPLGPRI | 1761 | D6RIA3 | |
| NGQSLPVSPRVKRPI | 276 | Q00888 | |
| ALLPVVFALPPKEGR | 26 | Q8WWT9 | |
| RRPFGQKASSLPPIV | 231 | Q9UHG0 | |
| NGQSLPVSPRVKRPI | 276 | P11464 | |
| TPPIARRVPFLKNKG | 981 | Q9BXW9 | |
| LAPSALPAGRVIKPQ | 141 | Q8TBJ5 | |
| FINPPIGTVTPALKL | 131 | Q9BY77 | |
| RVKLSNPPSAGPIVV | 1066 | Q15262 | |
| NGQSLPVSPRVKRPI | 276 | Q16557 | |
| TLNGAVEKPRPLALP | 811 | Q9BVI0 | |
| PAKLLLGATLPRAPR | 31 | P00540 | |
| RPIFIRGPASPKIVI | 201 | O15403 | |
| SRPPTEQLLKFPFIR | 276 | Q8N4C8 | |
| PIQLREGQLPLTPAK | 256 | Q6ZR62 | |
| KVSSGPRLPAPQIVA | 81 | Q92750 | |
| LGRKLPVSSAQPLFP | 366 | Q9UGK3 | |
| LKFDPLLRDSPGRPV | 561 | Q9Y6A5 | |
| TQPRLFNGVKVLPIP | 111 | Q8N490 | |
| LKPVTVPPRLAGASQ | 161 | Q5HYK7 | |
| RPSSPLIDIKPIEFG | 116 | Q9BSW7 | |
| LGAEPFPLRLPQRIV | 701 | Q9Y4C2 | |
| SLGAIVIPPIPKART | 231 | Q6ZUX3 | |
| LPPPLTRQIAVKTLG | 71 | Q9NXC2 | |
| RLPLPVSGFPQASRK | 471 | Q6UX01 | |
| PRQLGPVLRSPLTQK | 681 | Q9HCE1 | |
| GPKPFREVIAGPLLR | 166 | Q6DKJ4 | |
| LETGIPSPLERKVFP | 136 | Q9P212 | |
| PSPLERKVFPGIQLE | 141 | Q9P212 | |
| RVLFLIPKNNPPTLV | 226 | Q9P289 | |
| GQSLPVSPRVKRPIE | 276 | Q00889 | |
| NGQSLPVSPRVKRPI | 276 | Q9UQ74 | |
| PVSPGVKRPIENRIL | 281 | Q00887 | |
| VPNPLPKVLSRRGVG | 11 | O00291 | |
| PFDGPTLPILRQRVL | 216 | Q9H0K1 | |
| AQQLLKRPRGPSPLV | 561 | Q9Y2K2 | |
| PDRPVLKGLTFTLRP | 481 | Q03519 | |
| ESVPKVPIFLGKRPQ | 886 | Q6ZUB1 | |
| PSRLASIIGVKSLPP | 4071 | O75592 | |
| RVPQAEGPPKRVSLV | 1366 | Q14160 | |
| FLIGVPSPKLQVPSV | 746 | Q2Y0W8 | |
| VSTRSGRIIPKPEFP | 146 | Q96A35 | |
| RGVLIPFALSLPEKP | 601 | O94819 | |
| QGAPPSELIRLTKVP | 276 | O94993 | |
| FLETIETPRPGKLFP | 201 | Q13433 | |
| PKAGQVIPTLLREAP | 41 | Q53RT3 | |
| RPGTPPDFILKVVID | 86 | O95476 | |
| VLILPPRAGTPKLFN | 1096 | Q14028 | |
| RGPDALLTVALRKPP | 211 | O95398 | |
| PVPGPRAQLLRKFIK | 726 | O95398 | |
| PGCPAFIIVKLSPLR | 96 | Q86XI8 | |
| PVAVAGAPVFLRPLK | 36 | Q15772 | |
| GIVKSIPRGFLPPEL | 326 | O43511 | |
| DRGTVVEPLKPPALF | 466 | Q8NI35 | |
| LLAFQRPTIPRNPKG | 456 | Q9Y4K3 | |
| ENGLAVPVPLRKSRP | 401 | O94804 | |
| LLRGVSPTPSKIPVR | 11 | Q12815 | |
| PAVRTLKPPGRADLL | 271 | Q9Y6F9 | |
| CLPPSPGLITVRLKF | 166 | Q71RG4 | |
| KVVVPPLPGKAFLRQ | 86 | O60493 | |
| RLSPLKPLPLVGTFQ | 696 | Q9Y4R7 | |
| PEGTPQRILLKIFNP | 1136 | Q6AHZ1 | |
| KRLRQDPPLIFSPTG | 771 | Q9P2J2 | |
| RPLVPEVSIKTPRVF | 156 | P27708 | |
| EVTGPVIAPLFPQKR | 2046 | O75643 | |
| FVPVRPGPRQLIASL | 756 | P22735 | |
| RNAPPTAIGIPTKLL | 481 | Q9Y2B5 | |
| PTLQKFGLLRTDPVP | 41 | P55327 | |
| LLKPVFPGSVPSIRR | 466 | Q9NYU1 | |
| QGLAPPTVFLKALPI | 46 | Q5JPB2 | |
| QFPGKGPALLIAIRP | 66 | A0A075B6W5 | |
| IFSRKPPRTVSVLDP | 371 | Q96S53 | |
| LRFIPKPDGLRPIVN | 621 | O14746 | |
| RAKGRLPIPMVILPF | 591 | Q06418 | |
| GVPAPQKVLFPTERL | 96 | Q9P275 | |
| PVLPVRFLGISPRQI | 21 | Q8IZJ6 | |
| RPVPIKRFNGDVLSP | 301 | Q66K66 | |
| KDLNPFTPLVGIRIP | 161 | Q86U90 | |
| PAPVEVNLKLRRPSF | 296 | Q9BWF2 | |
| RVLAGSVPPTLTPKQ | 746 | A6NNM8 | |
| PPRKPASNLVGVLLG | 2751 | Q9Y493 | |
| RFLLAPPGRLVKAEP | 111 | Q9Y5W3 | |
| KPRGVAVNLIPGLPA | 1496 | Q9Y4I1 | |
| QTLPAPKQLRVRPTF | 446 | Q9UBF9 |